MabVax Therapeutics Holdings Inc (OTCQB:MBVX)

Data as of Jan 26
 +0.03 / +2.63%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.

Contact Information

MabVax Therapeutics Holdings, Inc.
11588 Sorrento Valley Road
San Diego California 92121
P:(858) 259-9405
Investor Relations:



Other institutional5.53%
Individual stakeholders1.63%
Mutual fund holders0.00%

Top Executives

John David HansenChairman, President & Chief Executive Officer
Gregory P. HansonChief Financial Officer
Philip O. LivingstonDirector & Chief Science Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.